Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS)

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 6, 2012, Pages 770-774

  Baysal, Elif ^a   Taysi, S ^a   Aksoy, N ^b   Uyar, M ^c   Celenk F ^a   Karatas, Z A ^a   Tarakcioglu, M ^a   Bilinc H ^b   Mumbuc S ^a   Kanlikama, M ^a  

^a Department of Otolaryngology ^*  (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Free radical; Obstructive sleep apnea syndrome; Paraoxonase; Total antioxidant status; Total oxidant status

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CERULOPLASMIN; LIPID HYDROPEROXIDE; THIOL DERIVATIVE;

ADULT; AGED; ANALYTICAL PARAMETERS; BLOOD SAMPLING; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PERIPHERAL VEIN; PROSPECTIVE STUDY; REVIEW; SLEEP APNEA SYNDROME; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; VOLUNTEER;

ADOLESCENT; ADULT; AGED; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84864263316     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. GUILLEMINAULT C, TILKIAN A, DEMENT WC. The sleep apnea syndromes. Annu Rev Med 1976; 27: 465-484.
2. COFTA S, WYSOCKA E, PIORUNEK T, RZYMKOWSKA M, BATURA-GABRYEL H, TORLINSKI L. Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 2008; 59(Suppl 6): 183-190.
3. AMERICAN ACADEMY OF SLEEP MEDICINE TASK FORCE. Sleep-related breathing disorders in adults:recommendations for syndrome definition and measurement techniIues in clinical research. Sleep 1999; 22: 667-689.
4. YOUNG T, PALTA M, DEMPSEY J, SKATRUD J, WEBER S, BADR S. The occurrence of sleep-disordered breathing among middle-Aged adults. N Engl J Med 1993; 328: 1230-1235.
5. MACKNESS B, DURINGTON PN, MACKNESS MI. Human serum paraoxonase. Gen Pharmacol 1998; 31: 329-336.
6. GOSWAMI B, TAYAL D, GUPTA N, MALLIKA V. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 2009; 410: 1-12.
7. ECKERSON HW, WYTE MC, LA DU BN. The human serum paroxonase/arylesterase polymorphism, Am J Hum Genet 1983; 35: 1126-1138.
8. CAMUZCUOGLU H, TOY H, VURAL M, CAMUZCUOGLU A, TASKIN A, CELIK H. Serum paraoxonase and arylesterase activities in iron deficiency anemia during pregnancy Turk J Med Sci 2011; 41: 185-191.
9. ISIK A, KOCA SS, USTUNDAG B, CELIK H, YILDIRIM A. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol 2007; 26: 342-348.
10. FREI B, STOCKER R, AMES BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85:9748-52.
11. CHRISTOU K, MOULAS AN, PASTAKA C, GOURGOULIANIS KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003; 4: 225-228.
12. KATSOULIS K, KONTAKIOTIS T, SPANOGIANNIS D. Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease. Sleep Breath 2011; 15: 861-866.
13. HAAGEN L, BROCK A. A new automated method for phenotyping arylesterase (E. C. 3. 1. 1. 2. ) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 1992; 30: 391-395.
14. EREL O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
15. EREL O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
16. HARMA M, HARMA M, KOCYIGIT A, EREL O. Increased DNA damage in patients with complete hydatidiform mole. Mutat Res 2005; 583: 49-54.
17. ELLMAN GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
18. HU ML, LOUIE S, CROSS CE, MOTCHNIK P, HALLIWELL B. Antioxidant protection against hyochlorous acid in human plasma. J Lab Clin Med 1993; 121: 257-262.
19. EREL O. Automated measurement of serum ferroxidase activity. Clin Chem 1998; 44: 2313-2319.
20. NOUROOZ ZADEH J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999; 300: 58-62.
21. AKTAN B, TAYSI S, GUMUSTEKIN K, UCUNCU H, MEMISOGULLARI R, SAVE K, BAKAN N. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. Pol J Pharmacol 2003; 55: 1105-1110.
22. SELEK S, CO AR N, KOÇYI IT A, EREL O, AKSOY N, GENCER M, GUNAK F, ASLAN M. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 2008; 41: 140-144.
23. ÇAKMAK A, ZEYREK D, ATAS A, SELEK S, EREL O. Oxidative status and paraoxonase activity in children with asthma. Clin Invest Med 2009; 32: 327-334.
24. SHIH DM, LUSIS AJ. The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Curr Opin Lipidol 2009; 20: 288-292.
25. TANIMOTO N, KUMON Y, SUEHIRO T, OHKUBO S, IKEDA Y, NISHIYA K, HASHIMOTO K. Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci 2003; 72: 2877-2885.
26. KOC S, AKSOY N, BILINC H, DUYGU F, UYSAL IO, EKINCI A. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol 2011; 75: 1364-1367.
27. YILMAZ T, KOÇAN EG, BESLER HT. The role of antioxidants in chronic tonsillitis and adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol 2004; 68: 1053-1058.
28. DYUGOVSKAYA L, LAVIE P, LAVIE L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939.
29. BARCELO A, BARBE F, DE LA PENA M, PEREZ G, PIEROLA J, DURAN J. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006; 27: 756-760.
30. LAVIE L, POLOTSKY V. Cardiovascular aspects in obstructive sleep apnea syndrome-molecular issues, hypoxia and cytokine profiles. Respiration 2009; 78: 361-370.
31. OZTURK L, MANSOUR B, YUKSEL M, YALCIN AS, CELIKOGLU F, GOKHAN N. Lipid peroxidation and osmotic fragility of red blood cells in sleep-Apnea patients. Clin Chim Acta 2003; 332: 83-88.
32. SVATIKOVA A, WOLK R, LERMAN LO, JUNCOS LA, GREENE EL, MCCONNELL JP, SOMERS VK. Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005; 26: 2435-2439.
33. WALI SO, BAHAMMAM AS, MASSAELI H, PIERCE GN, ILISKOVIC N, SINGAL PK, KRYGER MH. Susceptibility of LDL to oxidative stress in obstructive sleep-Apnea. Sleep 1998; 21: 290-296.
34. ALZOGHAIBI MA, BAHAMMAM AS. Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 2005; 9: 119-126.
35. KOTANI K, KIMURA S, TSUZAKI K, SAKANE N, KOMADA I, SCHULZE J, GUGLIUCCI A. Reduced paraoxonase 1/arylesterase activity and its post-Therapeutic increase in obstructive sleep apnea syndrome: a preliminary study. Clin Chim Acta 2008; 395: 184-185.